Group CBT for PTSD (GCBT)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01544088|
Recruitment Status : Active, not recruiting
First Posted : March 5, 2012
Last Update Posted : February 1, 2018
|Condition or disease||Intervention/treatment||Phase|
|PTSD||Behavioral: Group Cognitive Behavioral Treatment (GCBT) Behavioral: Present Centered Group Treatment||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||198 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Group CBT for Chronic PTSD: RCT With Veterans|
|Actual Study Start Date :||July 1, 2012|
|Actual Primary Completion Date :||August 23, 2017|
|Estimated Study Completion Date :||June 30, 2018|
Experimental: Arm 1
Group Cognitive Behavioral treatment (GCBT)
Behavioral: Group Cognitive Behavioral Treatment (GCBT)
GCBT is a 14 week intervention that includes components of exposure (imaginal and in vivo), cognitive restructuring, and relapse prevention.
Active Comparator: Arm 2
Present Centered Group Treatment
Behavioral: Present Centered Group Treatment
The active comparison treatment is a 14 week treatment that focuses on here and now problems, especially problem solving skills concerning ongoing stressors.
- Clinician Administered PTSD Scale (CAPS) [ Time Frame: 12 months ]The CAPS is a semi-structured interview to assess presence and severity of PTSD symptoms. The total score on the CAPS will be used as the primary outcome measure in this study.
- Beck Depression Inventory, II (BDI-II) [ Time Frame: 12 months ]The BDI is a self-report inventory that indexes depression symptom severity.
- Short-Form Health Survey (SF-36) [ Time Frame: 12 months ]The SF-36 is a measure of functional impairment.
- Beck Anxiety Inventory (BAI) [ Time Frame: 12 months ]The BAI is a self-report measure of general anxiety symptom severity.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01544088
|United States, Massachusetts|
|VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA|
|Boston, Massachusetts, United States, 02130|
|United States, Rhode Island|
|Providence VA Medical Center, Providence, RI|
|Providence, Rhode Island, United States, 02908|
|Principal Investigator:||Denise M Sloan, PhD||VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA|